Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05391971 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder

StatusActive, Not Recruiting
PhasePhase 4
Started2022-08-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 9, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-04-08
notable
Study Status, Study Design, Contacts/Locations v6
Trial status changed: Recruiting → Active, Not Recruiting
Primary completion pushed: 2026-03-01 → 2026-06-30
Completion pushed: 2026-04-01 → 2026-06-30
Enrollment targetestimated 80→confirmed 79
Study sitesdetails revised at 1 of 1 site
2026-01-02
minor
Study Status, Study Design v5
Primary completion date2025-06-10→2026-03-01
Completion date2025-08-15→2026-04-01
Enrollment target90→80
2025-02-24
minor
Study Status, Study Design, Contacts/Locations v4
Enrollment target127→90
2024-04-10
minor
Study Status v3
Primary completion date2024-05-01→2025-06-10
Completion date2024-06-15→2025-08-15
Start date2022-07-27→2022-08-01
2023-05-19
minor
Study Status, Contacts/Locations v2
Start date2022-06-27→2022-07-27
2022-06-27
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-06-06→confirmed 2022-06-27
Study sitesdetails revised at 1 of 1 site
2022-05-23
minor
Original filing
812 trials monitored
See 45 trials at risk
This study will enroll patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for post-traumatic stress disorder (PTSD). Following an initial screening visit, clinical assessment, and enrollment, subjects will be randomized into treatment and placebo arms. Both cohorts will undergo a pre-intervention functional magnetic resonance imaging (fMRI) of their brain. Treatment subjects will receive unilateral two-level stellate ganglion block via ultrasound-guided injection of anesthetic (bupivacaine) into the cervical sympathetic tissue; placebo subjects will receive an identical volume of saline via the same procedures. At approximately 4 weeks post-procedure, both cohorts will then undergo a post-intervention clinical assessment. Finally, both cohorts will undergo a post-intervention fMRI of their brain.
Trial Details
NCT Number NCT05391971
Lead Sponsor NYU Langone Health
Conditions Post Traumatic Stress Disorder
Enrollment 79 participants
Start Date 2022-08-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-09